Amgen

FDA Pharma Meetings for February
Motley Fool
Tue, 01/31/12 - 07:58 am
FDA
Amgen
Xgeva
Cell Therapeutics
Pixuvri
Vivus
Qnexa
Chelsea Therapeutics
Northera
Amgen Increases Sales but Misses Estimates on Earnings
Motley Fool
Sat, 01/28/12 - 11:30 am
Amgen
Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.
Yahoo/BusinessWire
Sat, 01/28/12 - 11:29 am
Micromet
Amgen
M&A
lawsuits
2 Biotech Acquisitions in 1 Day! Let's Throw a Party
Motley Fool
Sat, 01/28/12 - 11:28 am
Amgen
Micromet
M&A
Celgene
Avila
The Law Firm of Weiss & Lurie Investigates Micromet, Inc.
Yahoo/BusinessWire
Sat, 01/28/12 - 11:25 am
Micromet
Amgen
M&A
lawsuits
10 Health Care Stocks to Watch
The Street
Sat, 01/28/12 - 11:21 am
Alexion
Gilead Sciences
Biogen Idec
Amgen
Becton Dickinson
Celgene
Intuitive Surgical
Eli Lilly
St. Jude Medical
Stryker
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Seeking Alpha
Fri, 01/27/12 - 11:08 am
Alexion
Amgen
Ariad
Biogen Idec
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
Vertex Pharmaceuticals
Amgen Misses Fourth-Quarter Profit Estimates as Anemia Drug Sales Tumble
Bloomberg
Fri, 01/27/12 - 10:35 am
Amgen
earnings
Amgen Agrees to Purchase Micromet for $1.16 Billion to Gain Leukemia Drug
Bloomberg
Thu, 01/26/12 - 01:09 pm
Amgen
M&A
Micromet
leukemia
Why Amgen Is Overvalued At $70 A Share
Seeking Alpha
Mon, 01/23/12 - 12:46 pm
Amgen
Forbes Earnings Preview: Amgen
Forbes
Mon, 01/23/12 - 11:01 am
earnings
Amgen
10 Biotech Stocks With Strong Corporate Governance
Seeking Alpha
Wed, 01/18/12 - 10:03 am
Amgen
Achillion
Chelsea Therapeutics
Charles River Laboratories
Indenix
Human Genome Sciences
Incyte
Immunogen
NPS Pharmaceuticals
PDL Biopharma
Why Big Pharma Doesn't Really Need (Or Even Want) A Pipeline
Seeking Alpha
Tue, 01/17/12 - 06:48 pm
Adolor
Alexion
Amgen
Cubist Pharmaceuticals
AstraZeneca
Bristol-Myers Squibb
Inhibitex
Merck
Pfizer
Stryker
How Does Amgen Boost Its Returns?
Motley Fool
Sun, 01/15/12 - 01:37 pm
Amgen
7 Large-Cap Biotech Equities With Strong Momentum Right Now
Seeking Alpha
Sat, 01/14/12 - 11:32 am
Amgen
Ariad Pharmaceuticals
Biogen
Celgene
Gilead Sciences
Vertex Pharmaceuticals
30% Safe Upside For Merck, Amgen
Seeking Alpha
Thu, 01/12/12 - 10:54 am
Amgen
Merck
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wed, 01/11/12 - 10:58 am
Celldex
Amgen
Bristol-Myers Squibb
Dendreon
Seattle Genetics
Exelixis
Next Amgen CEO sees expansion to new markets, higher sales from newer products, share buybacks
Yahoo/AP
Tue, 01/10/12 - 09:05 am
Amgen
Pharma CEOs
Robert Bradway
2 ETFs To Play A Surge In Biotech/Pharma M&A
Seeking Alpha
Mon, 01/9/12 - 10:39 am
Abbott Laboratories
Amgen
Biogen Idec
Gilead
Celgene
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
ETFs
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
Xconomy
Mon, 01/9/12 - 10:10 am
JPMorgan
IPOs
Amgen
FDA
innovation

Pages